Drug intelligence / Profile preview

ursolic acid

Development stage
Phase 2
Lead developer
Sabinsa
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ursolic acid is a natural pentacyclic triterpenoid compound found in many fruits, vegetables, and medicinal plants such as apples, thyme, oregano, hawthorn, pears, olives, plums, cranberries and others[2][3][6][8]. It exhibits a wide range of biological activities including anti-inflammatory, antioxidant, anti-apoptotic, anti-carcinogenic (anticancer), antiviral and antibacterial effects[2][3][4][6][8]. Mechanistically, ursolic acid acts by inhibiting nuclear factor-kappa B (NF-κB) signaling pathways in cancer cells; suppressing STAT3 activation; inhibiting JNK expression; modulating IL-2 activation in T cells; weakly inhibiting aromatase activity; upregulating endothelial-type nitric oxide synthase (eNOS) and cystathionine-λ-lyase (CSE); scavenging reactive oxygen species (ROS); reducing apoptotic signaling; increasing adenosine monophosphate–activated protein kinase (AMPK) activity and irisin expression in skeletal muscle[2][3][6]. Preclinical studies suggest potential benefits for cancer prevention/treatment, obesity/diabetes management through improved insulin signaling and reduced fat accumulation/muscle atrophy prevention. Other areas of interest include cardiovascular disease protection via vasorelaxant properties and inhibition of metalloproteinases as well as neuroprotection through suppression of inflammatory pathways. Despite promising preclinical data across multiple indications—including cancer types (by regulating proliferation/metastasis/angiogenesis/apoptosis), cardiovascular diseases like atherosclerosis/fibrosis/aneurysm management/liver disease/muscle wasting—there are no approved clinical uses or demonstrated human health benefits to date[2][3][6].

Brand names
URSOLYX
Other names
3β-hydroxy-urs-12-en-28-oic acid
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on ursolic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ursolic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call